Arcus Biosciences, Inc.

Arcus Biosciences, Inc.

https://arcusbio.com/
Tags:ActiveBiopharmaBioTechDevelopmentDrugGrowthResearchScienceUniversity
Biotechnology company developing cancer immunotherapies targeting the adenosine and other oncology pathways
Location: United States, Hayward
Total raised: $177M

Investors 6

Funding Rounds 2

DateSeriesAmountInvestorsDeal News
13.11.2017Series C$107MGV-
01.09.2016Series B$70MGV-

Mentions in press and media 11

DateTitleDescriptionCategoryAuthorSource
09.03.2021Arcus Bios...HAYWARD, Calif.--(BUSINESS WIR...--oaoa.com/n...
24.02.2021Arcus Bios...HAYWARD, Calif.--(BUSINESS WIR...--oaoa.com/n...
28.05.2020Gilead ent...Under the deal, Gilead will pa...--medcitynew...
27.05.2019NYSE chang...“We are providing an improved ...--medcitynew...
20.02.2018Term Sheet...IT’S ALL RITE Good morning, T...--fortune.co...
13.11.2017Arcus Bios...Additional therapies are neede...--medcitynew...
13.11.2017Arcus Bios...HAYWARD, Calif.–(BUSINESS WIRE...--aislingcap...
05.09.2016Arcus Bios...Taiho Ventures, LLC today anno...--citybizlis...
01.09.2016Arcus Bios...Arcus Biosciences, a Hayward, ...USA-finsmes.co...
-Arcus Bios...HAYWARD, Calif.--(BUSINESS WIR...--oaoa.com/n...
Show more